Matthews International MATW Proceeds from disposition of marketable securities and other investments

Proceeds from disposition of marketable securities and other investments at other companies

CBIZCBZ

$3.64M-56.7%

AMN HealthcareAMN

$2.51M-65.4%

GCM Grosvenor Inc.GCMG

$2.61M-56.0%

Lexicon PharmaceuticalsLXRX

$35.7M-66.2%

SS&C TechnologiesSSNC

$7.6M+7,500%

Mercado LibreMELI

$3.61B-7.5%

Other financials

Income statement

See full

Revenue$258.6M-39.5%

Gross profit$102.0M-29.2%

Operating income-$3.2M-153%

Net income-$21.8M-145%

EPS (diluted)-$0.69-138%

Balance sheet

See full

Cash & equivalents$36.1M-10.3%

Total debt$662.1M-26.6%

Total equity$512.2M+25.5%

Total assets$1.5B-16.2%

Cash flow

See full

Operating cash flow-$15.4M—

CapEx$4.0M-53.7%

Free cash flow-$19.5M-708%

Valuation

See full

Market cap$821.56M+26.0%

Enterprise value$1.45B-4.4%

P/E84.6×—

P/S0.7×+0.3×

Profitability

See full

Gross margin36.3%+5.8pp

Operating margin2.3%-1.2pp

Net margin0.8%+0.4pp

FCF margin-8.3%-8.8pp

Returns & leverage

See full

Return on equity2.1%+1.1pp

Debt / equity1.3×-0.9×

Current ratio1.6×0.0×

Where this comes from

Reported directly by Matthews International in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: Matthews International’s 10-Q, filed July 28, 2023, on SEC EDGAR. View the filing →

Ask your AI about Matthews International's proceeds from disposition of marketable securities and other investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Matthews International's proceeds from disposition of marketable securities and other investments?: Matthews International (MATW) reported proceeds from disposition of marketable securities and other investments of $0 in Q2 2023.